Series A Preferred Stock SUBSCRIPTION AND INVESTMENT REPRESENTATION AGREEMENTSubscription and Investment Representation Agreement • April 18th, 2023 • Panbela Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT, dated as of April 14, 2023, is by and between Panbela Therapeutics, Inc., a Delaware corporation (the “Company”), and the undersigned subscriber (the “Subscriber”). In consideration of the mutual promises contained herein, and other good, valuable and adequate consideration, the parties hereto agree as follows:
